TTM
$3.17B
YoY change
+3.2%
5Y CAGR
+2.1%
Peak year (2025)
$3.79B
Cumulative EBITDA
$24.44B
EBITDA history chart for GE HealthCare (GEHC) from 2019 to 2025
Latest: $3.79B
EBITDA growth chart for GE HealthCare (GEHC) from 2019 to 2025
Latest: +3.2%
EBITDA history table for GE HealthCare (GEHC) from 2019 to 2025
| 2025 | $3.79B | +3.2% | +$119.00M | ||
| 2024 | $3.67B | +4.4% | +$153.00M | ||
| 2023 | $3.51B | +11.0% | +$348.00M | ||
| 2022 | $3.17B | -10.6% | −$375.00M | ||
| 2021 | $3.54B | +3.9% | +$134.00M | ||
| 2020 | $3.41B | +20.0% | +$568.00M | ||
| 2019 | $2.84B | — | — |
- 2025$3.79B+3.2%
- 2024$3.67B+4.4%
- 2023$3.51B+11.0%
- 2022$3.17B-10.6%
- 2021$3.54B+3.9%
- 2020$3.41B+20.0%
- 2019$2.84B—
EBITDA values are taken from GE HealthCare's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at GE HealthCare (GEHC)
According to GE HealthCare's latest reported financial statements, the company's current EBITDA (TTM) is $3.17B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA for GE HealthCare (GEHC) came in at $3.79B – edged up 3.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, GE HealthCare EBITDA compounded at +2.1% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak EBITDA at $3.79B, with the historical low of $2.84B recorded in 2019.
GE HealthCare EBITDA by Year
GE HealthCare EBITDA 2025: $3.79B
In 2025, GE HealthCare reported EBITDA of $3.79B, edged up 3.2% from 2024. This figure represents the highest annual value in the available history.
GE HealthCare EBITDA 2024: $3.67B
GE HealthCare EBITDA in 2024 was $3.67B, edged up 4.4% from 2023.
GE HealthCare EBITDA 2023: $3.51B
2023's EBITDA for GE HealthCare came in at $3.51B, grew 11.0% from 2022.
GE HealthCare EBITDA 2022: $3.17B
GE HealthCare posted EBITDA of $3.17B in 2022, declined 10.6% below 2021.
GE HealthCare EBITDA 2021: $3.54B
GE HealthCare EBITDA in 2021 was $3.54B.
See more financial history for GE HealthCare (GEHC).
Sector peers by EBITDA
Healthcare peers of GE HealthCare (GEHC), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
GE HealthCare (GEHC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation